Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(03): 239-243
DOI: 10.1055/s-0042-1750438
Case Report

Mass-Forming Chronic Pancreatitis: Diagnostic Performance of PET/CT

Ravikanth Reddy 
1   Department of Radiology, St. John's Hospital, Bengaluru, Karnataka, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Mass-forming chronic pancreatitis and pancreatic ductal adenocarcinoma are most commonly located in the head of pancreas, and there is a marked overlap in clinical features and imaging findings that makes it diagnostically challenging, although prognosis and management of both these entities differ. Differentiation is made even more difficult when surgical exploratory biopsy is obtained. Radical surgical resection remains the standard of care for pancreatic ductal adenocarcinoma and conservative treatment is effective for mass-forming chronic pancreatitis. Misdiagnosis of mass-forming chronic pancreatitis as pancreatic ductal adenocarcinoma results in unnecessary surgical intervention, and misdiagnosis of pancreatic ductal adenocarcinoma as mass-forming chronic pancreatitis results in delay in surgical intervention when required. Fluorodeoxyglucose-positron emission tomography/computed tomography can reliably be used for tissue characterization of mass-forming chronic pancreatitis and for monitoring disease response following treatment. Although differentiation of mass-like lesions of pancreas is reliably made on histopathology, significant false-negative rate is a major drawback that has a negative effect on diagnosis. This case report describes a rare presentation of mass-forming chronic pancreatitis with florid dystrophic calcifications in a 60-year-old male.

Keywords

mass-forming chronic pancreatitis - pancreatic ductal adenocarcinoma - dystrophic calcifications - computed tomography - PET/CT - histopathology


Publication History

Article published online:
25 August 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ren S, Chen X, Cui W. et al. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. Cancer Manag Res 2019; 11: 7857-7866
    CrossrefPubMedSearch in Google Scholar
  • 2 Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Cancer Imaging 2020; 20 (01) 52
    CrossrefPubMedSearch in Google Scholar
  • 3 Matsumoto I, Shinzeki M, Toyama H. et al. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. J Gastrointest Surg 2011; 15 (12) 2296-2298 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 4 Ruan Z, Jiao J, Min D. et al. Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head. Oncol Lett 2018; 15 (06) 9735-9744 [PubMed]
    PubMedSearch in Google Scholar
  • 5 Wolske KM, Ponnatapura J, Kolokythas O, Burke LMB, Tappouni R, Lalwani N. Chronic pancreatitis or pancreatic tumor? A problem-solving approach. Radiographics 2019; 39 (07) 1965-1982 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 6 Kamisawa T, Ryu JK, Kim MH, Okazaki K, Shimosegawa T, Chung JB. Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver 2013; 7 (04) 394-400 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 7 Ngwa T, Law R, Hart P, Smyrk TC, Chari ST. Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis. Pancreas 2015; 44 (04) 557-560 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 8 Papp K, Angst E, Seidel S, Flury-Frei R, Hetzer FH. The diagnostic challenges of autoimmune pancreatitis. Case Rep Gastroenterol 2015; 9 (01) 56-61
    CrossrefPubMedSearch in Google Scholar
  • 9 Wakabayashi T, Kawaura Y, Satomura Y. et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98 (12) 2679-2687 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 10 Ren S, Qian L, Daniels MJ, Duan S, Chen R, Wang Z. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis. Eur J Radiol 2020; 133: 109360 [PubMed]
    CrossrefPubMedSearch in Google Scholar
  • 11 Yoshioka M, Uchinami H, Watanabe G. et al. F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors. Springerplus 2015; 4: 154
    CrossrefPubMedSearch in Google Scholar
  • 12 Kato K, Nihashi T, Ikeda M. et al. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis. Clin Nucl Med 2013; 38 (06) 417-421 [PubMed]
    CrossrefPubMedSearch in Google Scholar